Open AccessGlycosylated Haemoglobin (HbA 1 c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients
Author(s) -
U. Kirthana Kunikullaya,
Jaisri Goturu
Publication year - 2014
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2014/7742.3996
Subject(s) - dyslipidemia , medicine , lipid profile , glycemic , diabetes mellitus , univariate analysis , cholesterol , endocrinology , type 2 diabetes , blood lipids , analysis of variance , post hoc analysis , multivariate analysis
Diabetic patients with concomitant dyslipidemia are often soft targets for cardiovascular disease and deaths. An early intervention to normalize circulating lipids has been shown to reduce cardiovascular morbidity and mortality. Glycosylated hemoglobin (HbA1c) is routinely used as a marker to indicate long-term glycemic control.